Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Finland
Sweden
Denmark
Norway
Latest
Trending
Followed

Apotea, Webcast, Q2'25

By Inderes7/18/2025, 7:30 AM
Apotea

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Johan Mårild
00:00 - 00:17

Hello and welcome to the Apotea Q2 presentation. The results will be presented by Pär Svärdson, CEO and co-founder of Apotea, and myself, Johan Mårild, CFO.

Pär Svärdson
00:19 - 00:34

So, hello. Um, we have had a good quarter with stable growth and increased profitability, and all our projects are on track. And, um, now year one, we look forward to hearing about the figures.

Johan Mårild
00:34 - 00:55

Yes. We had revenues in the quarter of 1,826,000,000 and a growth of 9.9% in the quarter. As Pär mentioned, we increased the profitability and region-adjusted EBIT margin in Q2 to 5.4%.

Pär Svärdson
00:56 - 03:03

And, um, if we look a little bit at what happened during the quarter, we can see that. As we said, the growth was mainly driven by demand. We improved profitability. Um, I think we mentioned last quarter, um, in Q1, that we had uncertainty in the world with, um, I mean, we have a full-scale war in Europe, a trade war globally, and more conflicts. Um, but we haven't seen any problems in our business. And I think our business is probably one of the most stable in all industries. But we will continue to, um, look at this because, um, the world is a little bit problematic at the moment. Um, we also launched a new Rx hub in the south of Stockholm. Um, we launched it in May and moved pharmacists from the other hubs in Stockholm, so we haven't really increased the capacity. But we have built the infrastructure needed to increase our capacity this autumn. So in the following quarters, we will probably see how we can improve our capacity with this hub. And we also had the inauguration of our fulfillment centre in Varberg. So within a few weeks, we will start delivering our first orders from Varberg. So that's a very big project, and it's very exciting for us. And it's going very well. And now they have user acceptance tests. Uh, I think today they have performance tests. So we see that we can reach all targets. So it's an amazing facility. And we really look forward to continuing our progress in these initiatives. start producing. Absolutely.

Johan Mårild
03:05 - 04:12

And with the growth in the quarter, we are now approaching 7 billion in rolling net revenues, rolling 12-month net revenues. And we have, for the same period, an adjusted EBIT margin of 4.9%. If we look closer into the numbers, you see our revenue development to the left. We had, as mentioned, a revenue increase in the quarter of 9.9%. And the growth was driven by increased demand. We have a continued underlying trend of more and more people wanting to buy Rx products online. That trend continues, and we had growth in OTC and traded goods of 5.1% in the quarter, and the growth was negatively impacted by the fact that Easter this year took place in Q2 and last year was in Q1 as well. We had a cold spring in Sweden.

Pär Svärdson
04:13 - 04:17

Uh, but now it's sunny. Exactly.

Johan Mårild
04:18 - 07:13

Uh, and uh, to the right you can see the gross margin development where there was a stable gross margin in the quarter compared to the same period last year, with a gross margin of 28%. And the gross margin was also stable. If you look in comparison to the previous quarter, we had good cost control, continued high capacity utilization in the quarter, and in combination with the stable gross margin, we managed to increase our profitability. As you can see on the left-hand side of this slide, we had an adjusted EBIT margin in the quarter of 5.4%, and the adjustments of 6.2 million were related to a revaluation of the shareholding in Apomera AB, where we have a minority stake, and that's an e-commerce company focused on the Finnish market. We had an EBIT margin in Q2 of 5.1%. And as we state in the report, and in line with previous communication, we expect to increase our costs related to the Varberg facility as we start production there and initially can expect somewhat lower capacity utilization. These factors will, like for like, initially have a somewhat negative impact on our margins. However, we expect to stay well within our financial target and over time, as we scale up production in Varberg, we can expect an increased impact on our efficiency and our customer offering, enabling us faster deliveries to the southern and western parts of Sweden. To the right, you can see a breakdown of our operating costs. And as you can see, personnel costs in relation to net revenue came down in Q2 compared to a year ago. That is also partly impacted by the fact that today we are using more external staffing. We had strong operating cash flow in Q2. We have a strong cash flow conversion or cash flow model supported by our profitability and high inventory turnover. We had operating cash flow in Q2 of 165 million. We had relatively low investments in Q2.

Pär Svärdson
07:15 - 07:17

That's approximately 80, isn't it? And with the growth in the quarter, we are now approaching 7 billion in rolling, um, net revenues, rolling 12-month net revenues.

Johan Mårild
07:19 - 09:58

And to the right, you can see a breakdown of our net working capital. As you can see, it fluctuates somewhat from quarter to quarter due to natural variations. And as of the end of June, we had somewhat lower inventory compared to March. We have a stable inventory turnover, and inventory turnover was 8.8-8.9. And that was in line with the same period last year and also previous quarters. We increased the return on capital employed compared to Q2 24 and achieved a return on capital employed of close to 34%, which is in line with the previous quarter's report. To the right. Uh, we present the net debt. Uh, we had a net negative debt at the end of June, i.e. a net cash position of 69 million Swedish kronor. And that was due to our strong operating cash flow and also relatively low investments in the quarter. So we continue to have a solid balance sheet. If we sum up the first half year of '25, we can conclude that we have had a solid growth year-to-date, June of 12.5%. The growth was driven by a strong Rx growth of 16%, and as you can see, it now accounts for approximately 38% of our net revenue. And historically, Rx has had stronger growth than non-Rx products. And we expect this trend to continue, meaning that over time it will gradually increase its share of net revenue. To the right, we present the adjusted EBIT development for the first six months, and we had an adjusted EBIT margin of 5.4%. And the adjustment for the first half of the year is related to the revaluation of the shareholding in Apomera AB. And we had an EBIT margin for the first six months of 5.2%. And the EBIT is slightly above our financial target.

Pär Svärdson
10:00 - 12:18

And if we look a little bit ahead, we want to continue to build the pharmacy of tomorrow. And what does it mean when we say we want to build the pharmacy of tomorrow? We want to strive to improve a little bit for our customers in automation and financials, making everything a little bit better. But we can never reach that goal because tomorrow we will have another tomorrow. So we will continue to strive. And that's our main focus. And we will continue to do that forever. Um, but if we should pick two, uh, focus areas for the next quarter, it will absolutely be, uh, to start production in Varberg. And, um, now they are testing, and in a few weeks, we will start delivering orders. And after that, we will ramp up the production as soon as it's safe, and we can see that we have a very high quality. And then we will start delivering more and more shipping methods, more and more areas on the West Coast and continue to build, and as you mentioned, to reach all these high-efficiency goals we have for Varberg. And, um, and so that's our main focus. The other focus, uh, going forward is, uh, I think at least that it is going to change the e-commerce business in a big way. So, uh, now we're going from seven developers in the AI team to 14, uh, so we can, like, have twice as many projects in parallel. And I think that's very important because we have a lot of use cases. We have a lot of projects we want to build, and we can see that they're very good projects and very beneficial for our customers, our sales, and our efficiency, among other things. But now we have to deliver, and we can see that it's a very important area. So that will be our main focus. And with that, I think we.

Johan Mårild
12:18 - 12:21

Yeah, we're opening up for questions.

Pär Svärdson
12:21 - 12:22

Thank you.

Operator
12:33 - 12:36

The next question comes from Johan Fred from SEB. Please go ahead.

Johan Fred
12:38 - 13:14

Good morning, guys, and thank you for taking my questions. A first one on the sales development, if I may. Um, so you reported a 5% growth in OTC, which is, of course, against a tough comparison and the cold weather backdrop. However, I've noticed many of your peers have reported improved sales towards the end of the quarter. Um, did you see something similar or any particular trends in the sales development in OTC throughout the quarter? It would be much helpful. Thank you.

Pär Svärdson
13:15 - 13:25

Um, I think, uh, the impact of the cold weather was quite stable over the quarter. Uh.

Johan Mårild
13:25 - 13:40

The impact of, I mean, of course, the Easter was in April. Um, and as mentioned, uh, the Easter period then had a like-for-like negative impact. So, um, yes.

Pär Svärdson
13:40 - 13:50

Yeah. And Rx was in a little bit higher demand at the end of the quarter compared to the beginning. So, no big changes, I would say.

Johan Fred
13:52 - 14:06

We have a lot of projects we want to build, and we can see that these are very good projects and very beneficial for our customers, for our sales, for our efficiency, and so on. Got it. And on that topic of the strong sales growth and Rx, are there any strategic initiatives from your side such as marketing, etc.? , behind the strong sales development in the quarter?

Pär Svärdson
14:07 - 14:34

Um, I think Rx is mainly driven by capacity, and we have opened a new hub and we will continue to hire more pharmacists for the hubs in Stockholm. And that will continue. So I think we have a lot of initiatives to increase growth. Uh, both this project and the Varberg projects, and so on. Uh, so we will continue with that.

Johan Fred
14:38 - 14:50

So, uh, just to clarify, then, you didn't expand marketing or push your offering more than usual during the quarter.

Pär Svärdson
14:51 - 14:52

No. Not really.

Johan Fred
14:53 - 15:19

No. Uh, both this, I project the Varberg projects and so on. Um, and if I may continue here on your sort of gross margin development, it's roughly flat but improved slightly year over year, despite what I assume is a negative mix effect from higher sales. Um, could you elaborate on the drivers behind the, uh, well, slight increase in gross margin that helped offset the negative mix.

Pär Svärdson
15:20 - 15:50

I think it's both contributions from suppliers that have positively impacted our performance. Uh, it's, um, I mean, we negotiate with our suppliers, we have better prices from them and better terms, but also we sell more of our own products with higher margins. So, it's a combination. So, but I mean, from my perspective, we have a stable margin. It's not increasing that much. It's more that it can go a little bit up and a little bit down.

Johan Fred
15:52 - 16:45

Uh, both this I projects to Varberg projects and so on. Uh, both the projects in Varberg and so on. Very clear. Uh, both the IT projects, the Varberg projects, and so on. Uh, and a final one, if I may, on your operating margin trajectory, you mentioned that you expect costs to increase as you ramp up Varberg. Uh, but still staying within our guidance range. Well, well, um, within your guidance range. However, given your current margin of 5.4%, the lower end of your guidance range is 2.4 percentage points lower than that. So, so quite a spread here. Could you help us provide any insight or indication of what we can expect in terms of margin development in the coming, say, two quarters, aside from the relatively wide margin range of 3 to 5%, please?

Pär Svärdson
16:46 - 17:11

Um, I think we will, uh, we have said that we want to guide within this 3 to 5. Um, but I think we will decrease a little bit, but not that much. Um, but we will still guide you with this. 3 to 5, to be sure. But, um, and that's why we say we will stay well within. So.

Johan Mårild
17:12 - 17:36

Yeah. And as mentioned, over time, we expect the increased efficiency and improvement in customer offering coming from Varberg as we scale up will have a positive impact that outweighs the initial lower capacity utilization from the facility.

Johan Fred
17:38 - 17:45

Got it, got it. But when you say not that much, is that sort of less than a percentage point, or how should we think about it?

Pär Svärdson
17:46 - 18:06

Um, hard questions. Um, um, I think we should stay with the guidance for 3 to 5. Uh, because, um, we will try to make it as small as possible, but we don't want to promise something that we might not be able to deliver. So. Yes.

Johan Mårild
18:08 - 18:10

And it should be okay. Yeah.

Johan Fred
18:11 - 18:34

Yes, yes, yes. Got it, got it, got it. And if I may, a final one then, perhaps an easy one. Easier one. Um, you mentioned the timeline on ramping up. Uh, you mentioned briefly in the presentation, but could you delve into the details on your timeline for your ramp-up in Q3, please?

Pär Svärdson
18:35 - 19:21

Um, I think, uh, within a few weeks, we will start delivering orders and, uh, as soon as possible, uh, as soon as we can see it's stable, we will ramp up. And I think especially when we see, okay, now it's stable, then we can probably ramp up quite fast. And that will probably be in late August or the beginning of September. Uh, but uh, I mean, again, we don't know. So, I mean, for us, it's a long-term project and it's more important that it's stable and of high quality. If it's two weeks more or less, it's.

Johan Fred
19:26 - 19:31

Yeah. Got it. Thank you. Those were all my questions for now. Thank you so much for taking the time.

Operator
19:37 - 19:42

The next question comes from Benjamin Wahlstedt from ABG Sundal Collier. Please go ahead.

Benjamin Wahlstedt
19:44 - 20:06

Hello. Uh, sorry for dwelling on the Varberg expansion. Uh, but a follow-up on previous questions. Um, could you clarify when you will start appreciating the Varberg warehouse, please? Is that when you sort of launch the initial orders, or is that when the orders ramp up, so to speak?

Johan Mårild
20:07 - 20:26

The, uh, I mean, from an accounting perspective, we start appreciating the asset when they are, uh, complete and finalized. And, uh, that means it will be, uh, during, uh, I mean, in conjunction with starting the production. However, uh, yeah, uh.

Pär Svärdson
20:27 - 20:29

The sign-off with the supplier.

Johan Mårild
20:29 - 20:32

And so during Q3, we expect that to start.

Benjamin Wahlstedt
20:34 - 20:54

Right. But in a couple of weeks, then, is how we should understand it. So halfway through Q3 is a decent estimate. All right. Uh, and then, um, I was wondering, could you say anything more, like qualitatively, about your progress in Varberg, any hiccups so far, or anything like that?

Pär Svärdson
20:55 - 21:26

I think you encounter like 20 or 30 small issues every day, but no major ones. And I mean, the reason for testing is to find all these small errors. We have the supplier, and they are fixing small issues every day. Uh, but no major issues. And everything is going according to plan. So, I think it's a very big project, and it's quite rare that everything is going according to plan, but it is indeed going according to plan. So we're very happy about that.

Benjamin Wahlstedt
21:28 - 21:52

Perfect. Thank you. Turning to your top line, you outlined a number of factors that negatively impacted your top line growth in the quarter. I was wondering if you could be more specific about your estimate of the impact from Easter and a cold spring, maybe in terms of numbers or effects. I know it's a difficult question, but maybe in terms of percentage point impact or a 6 million impact.

Johan Mårild
21:53 - 22:28

It's hard to say a specific number for Easter and also for the cold spring. Of course, we can see that we have had a clearly negative impact. And we're highlighting in the report some of the product categories that are especially impacted. And also, if you don't buy sunscreen, you might not buy painkillers, etc. . So, the effect then becomes bigger than just for the sunscreen, so to say.

Pär Svärdson
22:28 - 22:51

And I think, um, uh, if you aggregate several quarters, it's, uh, not a fact, but we will always have, uh, one quarter affect the next one and so on. So, um, I think if you look at the top line, you need to consider more than one quarter.

Benjamin Wahlstedt
22:54 - 23:11

Yep. Loud and clear. Uh, and then you also mentioned doubling your AI capacity. And I was wondering if you could give us an idea of the costs that this will entail. Uh, and perhaps a bit more like in concrete terms. What is this? Is it added headcount, new licenses, or what is it?

Pär Svärdson
23:12 - 23:53

Yes. I mean, you have the cost for salary, and it's quite low. Um, I mean, it's more about finding the right person, and you need to. So the problem is maybe not the cost. The problem is to find the right person, assign the right project for that person, and train them. Um, so I think, um, we are like 800 plus and hiring seven people. It's not a big cost compared to the rest, but it's very important that we find the right person.

Benjamin Wahlstedt
23:55 - 24:03

Perfect or sort of AI skilled people. Also significantly more expensive to hire than the other 800.

Pär Svärdson
24:05 - 24:13

Of course, a little bit, but not that significant. However, it's not a significant cost, but it is a very important project.

Benjamin Wahlstedt
24:15 - 24:20

All right. And also, if you don't buy sunscreen, you may not buy painkillers, etc. Uh, I think that's, uh, all I had for now. Thank you, thank you.

Operator
24:25 - 24:29

The next question comes from Victor Hanson from Carnegie. Please go ahead.

Victor Hanson
24:31 - 24:47

Morning, gentlemen. Victor, here, a couple of follow-up questions. I'll start with, um, um, so you lowered the valuation of, uh, of your Finnish enterprise in, in Q2 here. Uh, can you tell us a bit more about that?

Johan Mårild
24:48 - 25:26

Well, we have a small minority stake in Apomera AB, an e-commerce company that we invested in during 2022. And, uh, the shares were revalued in Q2 and are now valued at 1.5 million Swedish from 7.7. So, um, so it's, um, yeah, a small, uh, small investment and, uh, a fairly low number on the balance sheet remaining.

Victor Hanson
25:28 - 25:37

Victor, here are a couple of follow-up questions. But the revaluation was due to worse financial performance or other effects, or what? What drove the revaluation?

Johan Mårild
25:37 - 26:05

I mean, yes, we do a reevaluation and evaluate our assets every quarter. And, uh, now we decided to reevaluate the shareholding. As a result of a communication regarding a capital raise in the company, and also, I guess underlying that is part of the performance of Apomera AB.

Victor Hanson
26:07 - 26:12

Victor, here, a couple of follow-up questions. Understood. Uh, and then, uh, what about, uh, Norway?

Johan Mårild
26:14 - 26:15

What about it?

Victor Hanson
26:15 - 26:23

Going according to plan? Yeah. Victor, here, a couple of follow-up questions. Is it going according to plan? Uh, growing faster than the group. Is it approaching break-even?

Johan Mårild
26:25 - 26:51

It's growing. It continued to grow. I mean, it's growing faster than the group; however, we are balancing on a kind of break-even level year to date. And we are also, focusing hard to improve the customer offering in Norway. So, we intend to further accelerate that growth to new levels.

Pär Svärdson
26:54 - 27:15

And implement new technology for the Norwegian company so we can continue to grow and grow much faster. So, um, it's a very interesting market and I think, uh, there are huge opportunities. But, uh, we still need some more time before we can see it in the figures, I think. Yeah.

Victor Hanson
27:17 - 27:41

Okay. Understood. Uh, then, uh, there was a previous question on the service segment and your gross margins. Uh, but you have this relatively small service segment in terms of sales, at least. But, very high gross margins. Uh, I'm wondering, is there anything particularly boosting it this quarter, or would you consider this your new run rate for the service segment?

Johan Mårild
27:43 - 28:28

The overall growth in the service segment is driven by our efforts to enhance our purchasing terms. And part of that is due to our increased marketing contributions from our suppliers. And that has been somewhat visible in the figures for the past couple of quarters, I would say. And also, uh, in Q2. So, I mean, the effort to have better purchasing terms is something we do every day, but we also have a long-term objective, working according to strategic themes to improve that even further in the long term.

Victor Hanson
28:31 - 28:55

Okay. Great. So it seems like these levels are sustainable. Then, uh, my next question is, uh, on your SKUs, they continue to increase. Um, is this an important goal for you in itself? Uh, and how do you choose which products to add? Because there seem to be lots of new products, especially in the beauty segment. Uh, do you see any particular price competition in this segment also?

Pär Svärdson
28:56 - 29:37

Um, for us, it's very important to be a pharmacy. So we want to stay within the pharmacy area, but we want to grow the number of SKUs within the pharmacy area. And, uh, there are a lot of products in the beauty area. So we will absolutely continue to grow, but we want to stay in the pharmacy area and maintain competitive pricing. Yeah. I think it's, uh, quite tough competition in all areas. Um, so I don't think there's more competition in that area, but we want to be a competitor, so we want to compete with everyone. Absolutely.

Victor Hanson
29:39 - 30:01

Okay, perfect. Uh, perfect. And then, uh, next question, um, a follow-up on your private label. Um, there was a previous question on where you were in one of your answers? You spoke about private label, and I was curious. Out of your OTC and TGA sales currently, how much is private label now and how has it developed to date?

Johan Mårild
30:01 - 30:58

It's, it's, I mean, last year we mentioned it was roughly 1% of total sales. And I mean, it's a small number even though it's growing; the share of total sales is likely to more gradually increase over time, we expect, rather than a large increase in the short term. So, I mean, it remains in that range, even though it's growing faster than the overall group. And we're also about to launch and continue to launch new products in this area. And in order to achieve a larger scale in our own products, you first need to invent the product, or come up with the products, and then market them and get the customer to buy them, of course. So it's. Yeah. Yeah.

Victor Hanson
31:01 - 31:22

And then, uh, next question, um, a follow-up on your private label. And, uh, a final question from me, uh, on, uh, on AI and, uh, marketing. Um, so now we have AI operators summarizing all the info from the web pages, so you don't even have to visit them. And this is reshaping SEO. And I'm curious how you think this will impact you for the future.

Pär Svärdson
31:23 - 32:22

Um, everything from ChatGPT to SEO and so on will probably be affected quite a lot. And that's why we scale up our team so we can be at the forefront and ahead of our competitors because I think it's a very interesting area. And, um, I think, uh, the AI team wants to have a meeting with me to discuss how to identify use cases in that area. And they wanted to have the meeting today, but I have some other things to do today. But. But I think we will absolutely take a look at that and see how we can improve our customer offering through AI agents and so on. So we can come back to that in later quarterly updates. But, um, it will absolutely be a focus area for us.

Victor Hanson
32:25 - 32:27

Perfect. That's all the questions for me. Thank you.

Pär Svärdson
32:27 - 32:28

Thank you.

Johan Mårild
32:35 - 32:46

And then, uh, next question, um, a follow up on your private label. That was the final question. And with that, we thank you for participating. And we wish you all a pleasant summer. And, uh, yeah.

Pär Svärdson
32:47 - 32:47

Thank you very much.

Johan Mårild
32:48 - 32:49

Yes. Goodbye.

Continue to the webcast
Revenio Group Oyj, Q3'26
Language: English11/12/2026, 1:00 PM
Jukka Kainulainen Good afternoon, and welcome to the Revenio Group Corporation Q3 Earnings Call. My name is Jouni Toijala. I am the CEO. And then, again today we have Jukka Kainulainen, our CFO, on th…
Kamux, Q3'26
Language: English11/12/2026, 9:00 AM
Katerina Heterant Good morning. Welcome to the Kamux Q3 results presentation. My name is Katerina Heterant and I am Head of Investor Relations at Kamux. Today we shall go through the Q3 results presen…
Koskisen, Webcast, Q3'26
Language: Finnish11/12/2026, 8:00 AM
Jukka Pahta Hyvää huomenta ja tervetuloa tähän osavuosikatsaustilaisuuteen! Koskisen tammi–syyskuun osavuosikatsaustilaisuuteen lähdetään otsikolla: Koskisen liikevaihdon kasvu jatkui. Kohonneet kusta…
Reaktor, Q3'26
Language: Finnish11/11/2026, 9:00 AM
Pekka Horo Oikein hyvää aamupäivää kaikille ja tervetuloa tähän meidän webcastiimme. Olen Pekka Horo, Reaktorin toimitusjohtaja, ja kanssani täällä on tänään Antti Akkanen, joka aloitti lokakuussa Rea…
Savox, Q3'26
Language: English11/10/2026, 11:00 AM
Paulina Tanila Our speakers today are CEO Jerry Kettunen and CFO Juha Järvi. Jerry will give an overview of Savox as a company and go through the highlights of the quarter. After that, Juha will conti…
Raisio Oyj, Webcast, Q3'26
Language: Finnish11/10/2026, 10:00 AM
Elli Siltala Hyvää marraskuista päivää Raisiosta! Ja tervetuloa Raision tammi-syyskuun 2026 osavuosikatsauksen webcastiin! Pahoittelut pienistä teknisistä haasteista, mitä meillä oli tässä alussa. Min…
Mandatum Oyj, Audiocast, Q3'26
Language: English11/10/2026, 9:00 AM
Lotta Borgström Good morning, everyone, and welcome to the Mandatum Q3 2026 audiocast. My name is Lotta Borgström from Investor Relations. Joining me today are our CEO, Petri Niemisvirta, and our CFO,…
Solar foods Go-to-market Update
Language: English11/9/2026, 12:00 PM
Maria Hello everyone, and welcome to the Solar Foods go-to-market update. My name is Maria and I'm here today with our CEO, Rami Jokela, and CFO and Deputy CEO, Ilkka Saura. Also with us today is Heli…
Outokumpu, Webcast, Q3'26
Language: English11/6/2026, 12:30 PM
Johan Welcome to the third quarter results webcast. I am responsible for investor relations. We will start with the presentation from our CEO, Kati ter Horst, and our CFO, Marc-Simon Schaar. After the…
Endomines, Webcast, Q3'26
Language: English11/5/2026, 1:00 PM
Andy Turpin Hello, everyone, and welcome to Endomines' third-quarter results webcast. Thanks for joining us today. My name is Andy Turpin and I am the Chief Communications Officer here at Endomines. A…
Lemonsoft Oyj, Q3'26 webcast
Language: English11/5/2026, 11:00 AM
Unknown 1 Welcome to the Lemonsoft Q3 results presentation. We will start with the presentation from CEO Alpo Luostarinen, followed by the Q&A. You can send your questions throughout the event via the…
Enersense, Webcast, Q3'26
Language: English11/5/2026, 10:30 AM
Liisa Tamminen Hello and welcome to the Enersense Q3 2026 results webcast. My name is Liisa Tamminen from Enersense Investor Relations. And with me here I have our CEO, Kari Sundbäck, and CFO, Jan-Elo…
Sitowise, Q3'26
Language: English11/5/2026, 10:00 AM
Mari Reponen Good day everyone, and welcome to the Sitowise Q3 2026 results audiocast. My name is Mari Reponen, and I am responsible for strategy and IR here at Sitowise. And today with me are our act…
Orthex, Webcast, Q3'26
Language: English11/5/2026, 9:00 AM
Alexander Rosenlew Good morning and welcome to the Orthex Interim Report. My name is Alexander Rosenlew and with me I have Saara Mäkelä, CFO, and Hanna Kukkonen, our CMSO. We will take you through the…
Suominen Oyj, Q3'26
Language: English11/5/2026, 8:30 AM
Anni Luoma Good morning, everyone, and welcome to the Suominen Q3 webcast. My name is Anni Luoma. I am the Manager of External Communications and Investor Relations at Suominen. Here with me are our P…
Lumo, Webcast, Q3'26
Language: English11/5/2026, 8:00 AM
Niina Saarto Good morning, all. Welcome. This is Lumo Homes plc's third quarter result webcast. I am Niina Saarto from Treasury and Investor Relations. Today I have two gentlemen here with me, namely…
CapMan, Webcast, Q3'26
Language: English11/5/2026, 7:30 AM
Charlotte Good morning and welcome to this presentation of CapMan. Q3 2026 interim report. Presenting today we have Pia Kåll, CEO of CapMan. And after the presentation, we will have a Q&A session. You…
Marimekko, Webcast, Q3'26
Language: English11/4/2026, 12:00 PM
Anna Good afternoon. My name is Anna and I am the IRO of Marimekko. It is my pleasure to welcome you to our Q3 webcast. With me, I have our president and CEO, Tiina Alahuhta, who will walk you through…
Administer, Webcast, Q3'26
Language: Finnish11/4/2026, 9:00 AM
Kimmo Herranen Welcome to the Administer Q3 2026 interim report. Results. Meillä on se alkaa. I am Kimmo Herranen. Kalle Lehtonen. Also. Kaarina og. Yelken. Kalle Lehtonen En el coco. Madan. Parannus.…
Kempower, Webcast, Q3'26
Language: English11/4/2026, 8:30 AM
Unknown 1 Powering the planet. Kempower. We charge our planet for the better. By powering the electric movement. We enable quick and scalable EV charging solutions for everyone and everywhere. We ma…